These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 49134

  • 1. A study of complement components C3, C5, C6, C7, C8 and C9 in chronic membranoproliferative glomerulonephritis, systemic lupus erythematosus, poststreptococcal nephritis, idiopathic nephrotic syndrome and anaphylactoid purpura.
    Geiger H, Good RA, Day NK.
    Z Kinderheilkd; 1975; 119(4):269-78. PubMed ID: 49134
    [Abstract] [Full Text] [Related]

  • 2. Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.
    McLean RH, Michael AF.
    J Clin Invest; 1973 Mar; 52(3):634-44. PubMed ID: 4630981
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I, Seino J, Sudo K, Kinoshita Y, Saito T, Yoshinaga K.
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complement activation in renal disease.
    West CD.
    Uremia Invest; 1987 Nov; 8(3-4):225-35. PubMed ID: 6545495
    [Abstract] [Full Text] [Related]

  • 11. Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.
    Soothill JF.
    Clin Exp Immunol; 1967 Jan; 2(1):83-92. PubMed ID: 4166187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.
    Kohler PF, Ten Bensel R.
    Clin Exp Immunol; 1969 Feb; 4(2):191-202. PubMed ID: 4978055
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard HJ.
    J Exp Med; 1972 Mar 01; 135(3):549-66. PubMed ID: 5058233
    [Abstract] [Full Text] [Related]

  • 15. The functional significance of complement.
    Fearon DT, Ruddy S, Knostman JD, Carpenter CB, Austen KF.
    Adv Nephrol Necker Hosp; 1974 Mar 01; 4():15-35. PubMed ID: 4219991
    [No Abstract] [Full Text] [Related]

  • 16. Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implications.
    Leibowitch J, Leveille M, Halwachs L, Wattel S.
    Adv Nephrol Necker Hosp; 1980 Mar 01; 9():295-314. PubMed ID: 6773316
    [No Abstract] [Full Text] [Related]

  • 17. Glomerulonephritis in children: clinical and morphologic characteristics and mechanisms of glomerular injury.
    McDonald BM, McEnery PT.
    Pediatr Clin North Am; 1976 Nov 01; 23(4):691-706. PubMed ID: 136629
    [No Abstract] [Full Text] [Related]

  • 18. [Serial changes of lymphocyte subpopulations, anti-T cell antibodies, and circulating immune complexes in patients with lupus nephritis, nephrotic syndrome and poststreptococcal acute glomerulonephritis (author's transl)].
    Nakabayashi K, Yoshida M, Nagasawa T.
    Nihon Jinzo Gakkai Shi; 1981 Mar 01; 23(3):253-63. PubMed ID: 6975844
    [No Abstract] [Full Text] [Related]

  • 19. Glomerular complement components in human glomerulonephritis.
    Verroust PJ, Wilson CB, Cooper NR, Edgington TS, Dixon FJ.
    J Clin Invest; 1974 Jan 01; 53(1):77-84. PubMed ID: 4586873
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.